News Daily News Platelet Hyperreactivity Score May Improve CVD Risk Detection L.A. McKeown August 23, 2024
News Daily News ‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database Michael O'Riordan August 21, 2024
News Daily News Lp(a) Still Low Almost 1 Year After Last Olpasiran Injection: OCEAN(a)-DOSE Yael L. Maxwell August 19, 2024
News Daily News Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes Michael O'Riordan August 19, 2024
News Daily News CMS Announces Negotiated Medicare Prices for First 10 Drugs Yael L. Maxwell August 16, 2024
News Daily News Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors Yael L. Maxwell August 15, 2024
News Daily News Tirzepatide Provides Sustained BP Reduction in Overweight Adults Todd Neale August 15, 2024
News Daily News DES Best for In-Stent Restenosis, but DCBs Also Viable Michael O'Riordan August 13, 2024
News Daily News Studies Highlight Rapid Growth of Semaglutide Use, Risks of Some Online Sources Todd Neale August 12, 2024
News Features Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question L.A. McKeown August 09, 2024
News Daily News Sudden Deaths After Acute MI Have Dropped, but Early Weeks Remain Risky Yael L. Maxwell August 08, 2024
News Daily News Leadless CRT a Safe, Effective Way to Deliver Pacing: SOLVE-CRT Caitlin E. Cox August 05, 2024
News Daily News COVID-19 Vaccination Tied to Fewer CV Events in Large UK Study Todd Neale August 01, 2024
News Daily News SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results Yael L. Maxwell August 01, 2024
News Daily News Patch May Prevail Where Prior Wearable Defibrillators Faltered: Jewel IDE Study Caitlin E. Cox July 30, 2024
News Daily News Schoolwide Intervention May Improve Obesity Outcomes Over Time Yael L. Maxwell July 29, 2024
News Daily News Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF Michael O'Riordan July 26, 2024
News Daily News FDA Medical Devices Chief Jeff Shuren Announces Retirement L.A. McKeown July 24, 2024